Back to search
Cytomegalovirus Infections, Heart Transplantation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cytomegalovirus Infections, Heart Transplantation trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Cytomegalovirus Infections, Heart Transplantation trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Open label study to determine tolerability and efficacy of letermovir for CMV prophylaxis in heart and lung transplant recipients. The study hypotheses are: 1.…
Context Cytomegalovirus (CMV) infection is a frequent and potentially severe event in solid organ transplant (SOT) recipients. Most of available treatment dis…
CMV infection and disease remain a significant clinical challenge for pediatric solid organ transplant (SOT) recipients. Current prevention strategies are limit…
This is an open label trial in which letermovir will be given as prophylaxis for the prevention of cytomegalovirus (CMV) infection and disease to all heart tran…